Christopher Ogden, CFO: CytomX Therapeutics CTMX Sell · Filed 25/03/20

Trade details

Type: Insider sale
Amount: $5,130.6
Shares · price: 8,551 sh · $0.60 a share
Held after: 201,026 sh
Stock: CytomX Therapeutics CTMX
Person: Christopher OgdenCFO
Trade date: 25/03/18
Filed: 25/03/20
Days to filing: 2 days

Sold 4.1% of holdings

Share of holding sold: 4.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/16~25/04/17

Christopher Ogden's recent trades

Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,953
1,624 sh
$4,953
Filed 06/17
Traded 06/15
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$124.1K
19,323 sh
$124.1K
Filed 03/19
Traded 03/17
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$28.6K
10,614 sh
$28.6K
Filed 25/06/17
Traded 25/06/16
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$4,841
1,641 sh
$4,841
Filed 25/06/17
Traded 25/06/13
Christopher OgdenCFO
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$2,440
1,984 sh
$2,440
Filed 24/08/22
Traded 24/08/20